LONDON, May 10: Drugmakers Merck and GlaxoSmithKline have cut the price of cervical cancer shots in a deal that will deliver them to poor countries for less than 5 dollar a dose. The new record low price for human papillomavirus (HPV) vaccines should mean millions of girls in developing countries can be protected against the disease, the Global Alliance for Vaccines and Immunisations (GAVI) said on Thursday. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel